共 241 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2016)Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma Gastroenterology 150 835-853
[3]
Soerjomataram I(2016)Hepatocellular carcinoma Nat Rev Dis Primers 2 16018-459
[4]
Siegel RL(2016)Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma J Clin Oncol 34 452-1639
[5]
Torre LA(2013)Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma J Clin Oncol 31 1631-425
[6]
Jemal A(2015)The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence Nat Rev Cancer 15 409-2201
[7]
Bruix J(2017)Recent developments in radiotherapy N Engl J Med 377 2200-390
[8]
Reig M(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-34
[9]
Sherman M(2009)Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25-1353
[10]
Llovet JM(2018)The safety and efficacy of combination therapy of sorafenib and radiotherapy for advanced hepatocellular carcinoma: a retrospective study Intern Med 57 1345-1047